HUP0100054A1 - Amid-oldalláncot hordozó pirimidinil-oxi karbonsavszármazékok, eljárás előállításukra, alkalmazásuk és a vegyületeket tartalmazó gyógyszerkészítmények - Google Patents
Amid-oldalláncot hordozó pirimidinil-oxi karbonsavszármazékok, eljárás előállításukra, alkalmazásuk és a vegyületeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP0100054A1 HUP0100054A1 HU0100054A HUP0100054A HUP0100054A1 HU P0100054 A1 HUP0100054 A1 HU P0100054A1 HU 0100054 A HU0100054 A HU 0100054A HU P0100054 A HUP0100054 A HU P0100054A HU P0100054 A1 HUP0100054 A1 HU P0100054A1
- Authority
- HU
- Hungary
- Prior art keywords
- pyrimidinyloxi
- chains
- producing
- carrying
- carboxylic acid
- Prior art date
Links
- 125000003368 amide group Chemical group 0.000 title 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19748238 | 1997-10-31 | ||
DE19752904A DE19752904A1 (de) | 1997-10-31 | 1997-11-28 | Neue Carbonsäurederivate, die Amidseitenketten tragen, ihre Herstellung und Verwendung als Endothelin-Rezeptorantagonisten |
DE1998109376 DE19809376A1 (de) | 1998-03-05 | 1998-03-05 | Neue Carbonsäurederivate, die Amidseitenketten tragen, ihre Herstellung und Verwendung als Endothelin-Rezeptorantagonisten |
PCT/EP1998/006571 WO1999023078A2 (de) | 1997-10-31 | 1998-10-16 | Neue carbonsäurederivate, die amidseitenketten tragen, ihre herstellung und verwendung als endothelin-rezeptorantagonisten |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0100054A1 true HUP0100054A1 (hu) | 2002-02-28 |
HUP0100054A3 HUP0100054A3 (en) | 2002-03-28 |
Family
ID=27217881
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0100054A HUP0100054A3 (en) | 1997-10-31 | 1998-10-16 | Pyrimidinyloxi carboxylic acid derivatives, carrying amido side-chains, process for producing them, their use and medicaments containing the same |
Country Status (18)
Country | Link |
---|---|
US (1) | US6509341B1 (hu) |
EP (1) | EP1027338A2 (hu) |
JP (1) | JP2001521927A (hu) |
CN (1) | CN1278251A (hu) |
AU (1) | AU2266199A (hu) |
BG (1) | BG104396A (hu) |
BR (1) | BR9814951A (hu) |
CA (1) | CA2307770A1 (hu) |
HR (1) | HRP980560A2 (hu) |
HU (1) | HUP0100054A3 (hu) |
ID (1) | ID24278A (hu) |
IL (1) | IL135347A0 (hu) |
NO (1) | NO20002124L (hu) |
NZ (1) | NZ504316A (hu) |
PL (1) | PL340871A1 (hu) |
SK (1) | SK4592000A3 (hu) |
TR (1) | TR200001182T2 (hu) |
WO (1) | WO1999023078A2 (hu) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19806438A1 (de) * | 1998-02-17 | 1999-08-19 | Basf Ag | Neue Carbonsäurederivate mit 5-substituiertem Pyrimidinring, ihre Herstellung und Verwendung |
DE19933164A1 (de) * | 1999-07-20 | 2001-01-25 | Basf Ag | Neue Carbonsäurederivate mit 5,6 substituiertem Pyrimidinring, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten |
CA2408343A1 (en) * | 2000-05-11 | 2002-11-07 | Banyu Pharmaceutical Co., Ltd. | N-acyltetrahydroisoquinoline derivatives |
DE10025728A1 (de) * | 2000-05-25 | 2001-11-29 | Basf Ag | Neue Carbamate und Harnstoffe, ihre Herstellung und Verwendung als Endothelin-Rezeptorantagonisten |
WO2002064573A1 (de) * | 2001-02-14 | 2002-08-22 | Abbott Gmbh & Co. Kg | Neue carbonsäurederivate mit alkylsubstituierten triazinen, ihre herstellung und verwendung als endothelin-rezeptorantagonisten |
EP1243262B1 (en) | 2001-03-20 | 2006-05-31 | Schwarz Pharma Ag | Novel use of a peptide class of compound for treating non-neuropathic inflammatory pain |
EP1243263B1 (en) | 2001-03-21 | 2002-11-27 | Schwarz Pharma Ag | Novel use of a peptide class of compound for treating allodynia or other different types of chronic or phantom pain |
MXPA06011937A (es) | 2004-04-16 | 2007-01-26 | Sanol Arznei Schwarz Gmbh | Uso de compuestos peptidicos para la profilaxis y el tratamiento de dolor de cabeza cronico. |
EP1604656A1 (en) | 2004-06-09 | 2005-12-14 | Schwarz Pharma Ag | Novel use of peptide compounds for treating amyotrophic lateral sclerosis (ALS) |
BRPI0514721A (pt) | 2004-08-27 | 2008-06-24 | Sanol Arznei Schwarz Gmbh | uso de compostos de peptìdeos para tratar dor de cáncer ósseo, dor induzida por quimioterapia e nucleosìdeo |
KR20080111137A (ko) * | 2006-04-13 | 2008-12-22 | 액테리온 파마슈티칼 리미티드 | 초기 단계 특발성 폐 섬유증을 위한 엔도텔린 수용체 대항제 |
SI2462990T1 (sl) | 2006-06-15 | 2014-04-30 | Ucb Pharma Gmbh | Farmacevtski sestavek, ki obsega lakozamid in levetiracetam, s sinergističnim antikonvulzivnim učinkom |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4313412A1 (de) | 1993-04-23 | 1994-10-27 | Basf Ag | 3-(Het)aryl-Carbonsäurederivate, Verfahren und Zwischenprodukte zu ihrer Herstellung |
DE4313413A1 (de) * | 1993-04-23 | 1994-10-27 | Basf Ag | 3-(Het)aryloxy(thio)-Carbonsäurederivate, Verfahren und Zwischenprodukte zu ihrer Herstellung |
DE4411225A1 (de) | 1994-03-31 | 1995-10-05 | Basf Ag | Verwendung von Carbonsäurederivaten als Arzneimittel |
DE19533023B4 (de) * | 1994-10-14 | 2007-05-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
DE19614534A1 (de) | 1996-04-12 | 1997-10-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
-
1998
- 1998-10-16 US US09/529,860 patent/US6509341B1/en not_active Expired - Fee Related
- 1998-10-16 CA CA002307770A patent/CA2307770A1/en not_active Abandoned
- 1998-10-16 HU HU0100054A patent/HUP0100054A3/hu unknown
- 1998-10-16 NZ NZ504316A patent/NZ504316A/xx unknown
- 1998-10-16 IL IL13534798A patent/IL135347A0/xx unknown
- 1998-10-16 ID IDW20000816A patent/ID24278A/id unknown
- 1998-10-16 AU AU22661/99A patent/AU2266199A/en not_active Abandoned
- 1998-10-16 PL PL98340871A patent/PL340871A1/xx unknown
- 1998-10-16 JP JP2000518953A patent/JP2001521927A/ja active Pending
- 1998-10-16 SK SK459-2000A patent/SK4592000A3/sk unknown
- 1998-10-16 WO PCT/EP1998/006571 patent/WO1999023078A2/de not_active Application Discontinuation
- 1998-10-16 EP EP98966230A patent/EP1027338A2/de not_active Withdrawn
- 1998-10-16 BR BR9814951-2A patent/BR9814951A/pt not_active IP Right Cessation
- 1998-10-16 TR TR2000/01182T patent/TR200001182T2/xx unknown
- 1998-10-16 CN CN98810875A patent/CN1278251A/zh active Pending
- 1998-10-26 HR HR19809376.4A patent/HRP980560A2/hr not_active Application Discontinuation
-
2000
- 2000-04-26 NO NO20002124A patent/NO20002124L/no not_active Application Discontinuation
- 2000-05-02 BG BG104396A patent/BG104396A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP1027338A2 (de) | 2000-08-16 |
HRP980560A2 (en) | 1999-08-31 |
HUP0100054A3 (en) | 2002-03-28 |
NZ504316A (en) | 2002-12-20 |
TR200001182T2 (tr) | 2000-11-21 |
NO20002124D0 (no) | 2000-04-26 |
PL340871A1 (en) | 2001-03-12 |
CN1278251A (zh) | 2000-12-27 |
CA2307770A1 (en) | 1999-05-14 |
WO1999023078A3 (de) | 1999-09-10 |
ID24278A (id) | 2000-07-13 |
WO1999023078A2 (de) | 1999-05-14 |
AU2266199A (en) | 1999-05-24 |
NO20002124L (no) | 2000-04-26 |
SK4592000A3 (en) | 2000-12-11 |
JP2001521927A (ja) | 2001-11-13 |
US6509341B1 (en) | 2003-01-21 |
BR9814951A (pt) | 2000-10-03 |
IL135347A0 (en) | 2001-05-20 |
BG104396A (en) | 2001-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3036214T3 (en) | Phenylacetic acid derivatives, process and intermediate products for use in producing them and agents containing them | |
HUP0003073A3 (en) | Benzenesulfonamide derivatives, process for producing them and their use as medicines | |
HK1028769A1 (en) | 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof | |
HUP0001322A3 (en) | Sulphinic acid derivatives, method for producing them, and their use | |
HU9602339D0 (en) | Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof | |
HUP9901478A3 (en) | Carboline derivatives, their use, production thereof and medicaments containing the same | |
HU9802422D0 (en) | Substituted isoquinoline-3-carboxamide derivatives, process for producing them and their medical use | |
PL345863A1 (en) | Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments | |
HUP9701270A3 (en) | Neuraminic acid derivatives, medicaments containing them and their use for producing medicaments | |
HUP0002300A3 (en) | Quinoline-4-carboxamide derivatives, process for producing them, pharmaceutical compositions containing them and their use | |
HUP9901312A3 (en) | Novel alfa-hydroxylic acid derivatives, their production and use | |
HUP0100054A3 (en) | Pyrimidinyloxi carboxylic acid derivatives, carrying amido side-chains, process for producing them, their use and medicaments containing the same | |
HU9802132D0 (en) | Biphenyl-sulfonyl-cyanamides, process for producing them and their medical use | |
HUP9901376A3 (en) | 1-methylcarbapenem derivatives, their use, production thereof and medicaments containing the same | |
HU9501041D0 (en) | Peptide-boronic acid derivatives, process for producing them and pharmaceutical application thereof | |
HUP9901315A3 (en) | New carboxzlic acid derivatives, their production and use | |
IL134572A (en) | Substituted 1,2,3,4,5,6-hexahydro-2, 6-methano-3-benzazocin - 10 -ols, methods for their production and use thereof as medicaments | |
HUP9903902A3 (en) | Bromotiacumicin compounds, process for producing them and medicaments containing the same | |
HUP9600665A2 (en) | Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation | |
HUP9800472A3 (en) | New benzoxazinedion derivatives, process for producing them and pharmaceutical copositions containing them | |
HUP0102837A3 (en) | Phosphinous and phosphonic acid derivatives, their use medicaments containing the same and process for producing them | |
HUP9904603A3 (en) | Vitamin d3 derivatives, medicaments containing the same and process for production thereof | |
HRP930131A2 (en) | Amino-ascorbic acid derivatives, process for the preparation and use thereof | |
HUP9904592A3 (en) | 1,2-dithiolane-derivatives, process for their production and medicaments containing them | |
GR3034797T3 (en) | Carboxylic acid derivatives, their preparation and their use |